The Conversation: You’ve reached your weight loss goal on GLP‑1 medications – what now?
Weight loss on GLP-1 drugs can follow similar patterns as the yo-yo dieting fads of previous decades. RapidEye/iStock via Getty Images GLP-1 drugs have ushered in a new era in weight loss. In just a ...
You’ve reached your weight loss goal on GLP‑1 medications – what now?
Skye Bioscience is rated Buy, driven by nimacimab’s strong safety, durable weight-loss profile, and upcoming Phase 2a results. SKYE’s nimacimab targets the expanding anti-obesity market, showing ...
Eli Lilly (LLY) shares traded flat on Thursday as J.P. Morgan argued that adverse events overshadowed a potentially best-in-class weight loss profile indicated for its next-gen obesity therapy, ...
Seeking Alpha: ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
MSN: Eli Lilly confirms 'superior weight loss' of its next-generation obesity drug
Eli LillyLLY reported late-stage study results Thursday that confirmed the "superior weight loss profile" of its next-generation obesity treatment, retatrutide. On average, diabetic patients taking a ...
Most people think of weight loss as a math problem: calories in versus calories out. In reality, your body sees it as a survival threat. When calorie intake falls or body fat decreases, biological ...
Healio: Amylin analog induces up to 10.7% weight loss at 42 weeks with ‘favorable’ safety profile
Amylin analog induces up to 10.7% weight loss at 42 weeks with ‘favorable’ safety profile
Whether you’re shedding pounds with the help of effective new medicines, slimming down after weight loss surgery or cutting calories and adding exercise, there will come a day when the numbers on the ...